Targeting the extra domain A of fibronectin for cancer therapy with CAR-T cells (vol 10, e004479corr1, 2022)

被引：1
|
作者：
Martin-Otal, C. [1 ]
Lasarte-Cia, A.
Serrano, D.
机构：
[1] Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2022年 / 10卷 / 09期
关键词：
D O I：
10.1136/jitc-2021-004479corr1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 49 条
  • [1] Targeting the extra domain A of fibronectin for cancer therapy with CAR-T cells
    Martin-Otal, Celia
    Lasarte-Cia, Aritz
    Serrano, Diego
    Casares, Noelia
    Conde, Enrique
    Navarro, Flor
    Sanchez-Moreno, Ines
    Gorraiz, Marta
    Sarrion, Patricia
    Calvo, Alfonso
    De Andrea, Carlos E.
    Echeveste, Jose
    Vilas, Amaia
    Rodriguez-Madoz, Juan Roberto
    San Miguel, Jesus
    Prosper, Felipe
    Hervas-Stubbs, Sandra
    Lasarte, Juan Jose
    Lozano, Teresa
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (08)
  • [2] TARGETING THE EXTRA DOMAIN A FROM FIBRONECTIN FOR CANCER THERAPY WITH CAR-T CELLS
    Martin-Otal, C.
    Lasarte-Cia, A.
    Serrano, D.
    Casares, N.
    Navarro, F.
    Sarrion, P.
    Gorraiz, M.
    De-Andrea, C.
    Echeveste, J.
    Rodriguez-Madoz, J. R.
    Miguel, J. San
    Prosper, F.
    Hervas-Stubbs, S.
    Lasarte, J. J.
    Lozano, T.
    HUMAN GENE THERAPY, 2022, 33 (7-8) : A9 - A10
  • [3] CAR-T Therapy Targets Extra Domain B of Fibronectin Positive Solid Tumor Cells
    Tang, Jie
    Liu, Nan
    Zhu, Yongjie
    Li, Yi
    Zhao, Xudong
    IMMUNOLOGICAL INVESTIGATIONS, 2023, 52 (08) : 985 - 996
  • [4] ROR1-targeting switchable CAR-T cells for cancer therapy(Vol 41, Pg 4104, 2022)
    Peng, Haiyong
    Nerreter, Thomas
    Mestermann, Katrin
    Wachter, Jakob
    Chang, Jing
    Hudecek, Michael
    Rader, Christoph
    ONCOGENE, 2024, 43 (13) : 992 - 992
  • [5] ROR1-targeting switchable CAR-T cells for cancer therapy
    Haiyong Peng
    Thomas Nerreter
    Katrin Mestermann
    Jakob Wachter
    Jing Chang
    Michael Hudecek
    Christoph Rader
    Oncogene, 2022, 41 : 4104 - 4114
  • [6] ROR1-targeting switchable CAR-T cells for cancer therapy
    Peng, Haiyong
    Nerreter, Thomas
    Mestermann, Katrin
    Wachter, Jakob
    Chang, Jing
    Hudecek, Michael
    Rader, Christoph
    ONCOGENE, 2022,
  • [7] ROR1-targeting switchable CAR-T cells for cancer therapy
    Peng, Haiyong
    Nerreter, Thomas
    Mestermann, Katrin
    Wachter, Jakob
    Chang, Jing
    Hudecek, Michael
    Rader, Christoph
    ONCOGENE, 2022, 41 (34) : 4104 - 4114
  • [8] CAR-T therapy: Prospects in targeting cancer stem cells
    Cui, Xiaoyue
    Liu, Rui
    Duan, Lian
    Cao, Dan
    Zhang, Qiaoling
    Zhang, Aijie
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2021, 25 (21) : 9891 - 9904
  • [9] Correction: ROR1-targeting switchable CAR-T cells for cancer therapy
    Haiyong Peng
    Thomas Nerreter
    Katrin Mestermann
    Jakob Wachter
    Jing Chang
    Michael Hudecek
    Christoph Rader
    Oncogene, 2024, 43 : 992 - 992
  • [10] ADAM10-targeting CAR-T cells inhibit colon cancer cell growth in vivo.
    Rad, Elaheh Rohani
    Foeng, Jade
    McPeak, Dylan
    Tyllis, Timona
    Abbott, Caitlin
    bandara, Veronika
    Napoli, Silvana
    gundsambuu, Batjargal
    Barry, Simon
    Sadlon, Timothy
    McColl, shaun
    CANCER RESEARCH, 2022, 82 (12)
12345